Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Product code: K9652 (96 wells)

Determination of free anti-adalimumab antibodies

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-adalimumab antibodies in plasma or serum samples. Detecting high levels of free anti-adalimumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Please contact us for your nearest test reference laboratory.

Key Advantages

Supports the investigation of primary non-response and loss of response to adalimumab
Highly sensitive assay that only detects free anti-adalimumab antibodies
May help predict long term outcome of disease
Applicable to both gastroenterology and rheumatology
Automatable on ELISA automates (e.g. Dynex DS2)

Specifications

ELISA

45 tests

Storage: 2-8 °C

Blood sample


Related Products

    Adalimumab Drug Level ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples.

    Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.